Zeitschriftenartikel (61)

2019
Zeitschriftenartikel
Rebitschek, F. G., Reisel, D., Lein, I., & Wegwarth, O. (2019). Epigenetic risk assessment of female cancers: Women's information needs and attitudes. Public Health Genomics, 22(1-2), 46–57. https://doi.org/10.1159/000501975
Zeitschriftenartikel
Wegwarth, O., Pashayan, N., Widschwendter, M., & Rebitschek, F. G. (2019). Women's perception, attitudes, and intended behavior towards predictive epigenetic risk testing for female cancers in 5 European countries: A cross-sectional online survey. BMC Public Health, 19, Article 667. https://doi.org/10.1186/s12889-019-6994-8
2018
Zeitschriftenartikel
Mühlbauer, V., Prinz, R., Mühlhauser, I., & Wegwarth, O. (2018). Alternative package leaflets improve people's understanding of drug side effects - A randomized controlled exploratory survey. PLoS ONE, 13(9), Article e0203800. https://doi.org/10.1371/journal.pone.0203800
Zeitschriftenartikel
Wegwarth, O. (2018). Brustkrebsfrüherkennung - Nutzen und Risiken richtig kommunizieren. Der Gynäkologe, 51(5), 370–379. https://doi.org/10.1007/s00129-018-4199-3
Zeitschriftenartikel
Wegwarth, O., & Gigerenzer, G. (2018). US gynecologists' estimates and beliefs regarding ovarian cancer screening's effectiveness 5 years after release of the PLCO evidence. Scientific Reports, 8, Article 17181. https://doi.org/10.1038/s41598-018-35585-z
Zeitschriftenartikel
Wegwarth, O., Widschwendter, M., Cibula, D., Sundström, K., Portuesi, R., Lein, I., Rebitschek, F. G., & FORECEE (4C) Consortium. (2018). What do European women know about their female cancer risks and cancer screening? A cross-sectional online intervention survey in five European countries. BMJ Open, 8, Article e023789. https://doi.org/10.1136/bmjopen-2018-023789
Zeitschriftenartikel
Widschwendter, M., Jones, A., Evans, I., Reisel, D., Dillner, J., Sundström, K., Steyerberg, E. W., Vergouwe, Y., Wegwarth, O., Rebitschek, F. G., Siebert, U., Sroczynski, G., de Beaufort, I. D., Bolt, I., Cibula, D., Zikan, M., Bjørge, L., Colombo, N., Harbeck, N., Dudbridge, F., Tasse, A.-M., Knoppers, B. M., Joly, Y., Teschendorff, A. E., Pashayan, N., & the FORECEE (4C) Consortium. (2018). Epigenome-based cancer risk prediction: Rationale, opportunities and challenges. Nature Reviews Clinical Oncology, 15(5), 292–309. https://doi.org/10.1038/nrclinonc.2018.30
2017
Zeitschriftenartikel
Donner-Banzhoff, N., Seidel, J., Sikeler, A. M., Bösner, S., Vogelmeier, M., Westram, A., Feufel, M., Gaissmaier, W., Wegwarth, O., & Gigerenzer, G. (2017). The phenomenology of the diagnostic process: A primary-care based survey. Medical Decision Making, 37(1), 27–34. https://doi.org/10.1177/0272989X16653401
Zeitschriftenartikel
Wegwarth, O., Wagner, G. G., & Gigerenzer, G. (2017). Can facts trump unconditional trust? Evidence-based information halves the influence of physicians' non-evidence-based cancer screening recommendations. PLoS ONE, 12(8), Article e0183024. https://doi.org/10.1371/journal.pone.0183024
2016
Zeitschriftenartikel
McDowell, M., Rebitschek, F. G., Gigerenzer, G., & Wegwarth, O. (2016). A simple tool for communicating the benefits and harms of health interventions: A guide for creating a fact box. MDM Policy & Practice, 1, Article 2381468316665365. https://doi.org/10.1177/2381468316665365
2015
Zeitschriftenartikel
Prinz, R., Feufel, M. A., Gigerenzer, G., & Wegwarth, O. (2015). What counselors tell low-risk clients about HIV test performance. Current HIV Research, 13(5), 369–380. https://doi.org/10.2174/1570162X13666150511125200
Zeitschriftenartikel
Wegwarth, O. (2015). Medizinische Risikokommunikation: Nutzen und Schaden transparent kommunizieren. Forum: Das Offizielle Magazin der Deutschen Krebsgesellschaft e. V., 30(3), 208–213. https://doi.org/10.1007/s12312-015-1303-7
Zeitschriftenartikel
Wegwarth, O. (2015). Cancer survival rates: The CONCORD-2 study. The Lancet, 386(9992), 429–429. https://doi.org/10.1016/S0140-6736(15)61442-8
2014
Zeitschriftenartikel
Wegwarth, O. (2014). Transparent risk communication in cancer screening: Reveal when it's good and when it's not. Oncology Research and Treatment, 37(Suppl. 3), 6–7. https://doi.org/10.1159/000367912
Zeitschriftenartikel
Wegwarth, O., & Gigerenzer, G. (2014). Improving evidence-based practices through health literacy - in reply. JAMA Internal Medicine, 174(8), 1413–1414. https://doi.org/10.1001/jamainternmed.2014.846
Zeitschriftenartikel
Wegwarth, O., Kurzenhäuser-Carstens, S., & Gigerenzer, G. (2014). Overcoming the knowledge-behavior gap: The effect of evidence-based HPV vaccination leaflets on understanding, intention, and actual vaccination decision. Vaccine, 32(12), 1388–1393. https://doi.org/10.1016/j.vaccine.2013.12.038
Zeitschriftenartikel
Wegwarth, O., & Prinz, R. (2014). Risikokommunikation: Medizinische Risiken verstehen und verständlich machen. Zentralblatt fur Arbeitsmedizin, Arbeitsschutz und Ergonomie, 64(5), 320–324. https://doi.org/10.1007/s40664-014-0053-1
2013
Zeitschriftenartikel
Gigerenzer, G., & Wegwarth, O. (2013). Five year survival rates can mislead. BMJ, 346, Article f548. https://doi.org/10.1136/bmj.f548
Zeitschriftenartikel
Wegwarth, O. (2013). Statistical illiteracy in residents: What they do not learn today will hurt their patients tomorrow. Journal of Graduate Medical Education, 5(2), 340–341. https://doi.org/10.4300/JGME-D-13-00084.1
Zeitschriftenartikel
Wegwarth, O. (2013). Krebsfrüherkennung und Risikokommunikation. Therapeutische Umschau, 70(4), 245–250. https://doi.org/10.1024/0040-5930/a000396
Zur Redakteursansicht